K. Hofner et al., Tamsulosin 0.4 mg once daily: Effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction, EUR UROL, 36(4), 1999, pp. 335-341
Objective: To evaluate the effect of tamsulosin, 0.4 mg once daily, on sexu
al function in comparison with placebo and alfuzosin, 2.5 mg three times da
ily, in patients with lower urinary tract symptoms (LUTS) suggestive of ben
ign prostatic obstruction (BPO). Methods: Data from 830 patients randomized
into three European multicenter studies with similar protocols were analyz
ed. In two studies, patients were randomized to receive either tamsulosin,
0.4 mg once daily, or placebo, and in the third, patients were randomized t
o receive either a fixed dose of tamsulosin, 0.4 mg once daily, or alfuzosi
n, titrated to 2.5 mg three times daily. The studies employed a 2-week plac
ebo run-in period, followed by a 12-week study period. Sexual function was
assessed by related adverse events and by a sexual function score determine
d from a life-style questionnaire. Results: Abnormal ejaculation occurred s
ignificantly more frequently in patients treated with tamsulosin than in th
ose receiving placebo (p = 0.045); however, the incidence of abnormal ejacu
lation was similar in patients receiving tamsulosin or alfuzosin in the com
parative study. Abnormal ejaculation was not perceived as a major problem b
y the patients since it resulted in few treatment discontinuations (n = 3).
It was also reversible on drug withdrawal. There was no difference between
tamsulosin and placebo or alfuzosin with regard to the occurrence of decre
ased libido or impotence. In addition, there was no significant difference
in the change in sexual function score between patients treated with tamsul
osin and those treated with alfuzosin. Compared with patients receiving pla
cebo, there was, however, a significant improvement in total sexual functio
n score in patients receiving tamsulosin (p = 0.042). Conclusions: Tamsulos
in, 0.4 mg once daily, is well tolerated and has no overall negative impact
on sexual function compared with placebo or alfuzosin. Compared with place
bo, tamsulosin may even improve sexual function.